ARMI will attend BIO 2026 to connect with biotechnology leaders, explore partnership opportunities, and engage in discussions shaping the future of advanced biomanufacturing and regenerative medicine.
ARMI Chief Operating Officer Jennifer MacDonald will participate in a panel discussion at the Cell & Gene Therapy Summit 2026, exploring the scientific, manufacturing, regulatory, and commercialization challenges involved in bringing advanced therapies to patients.
ARMI will attend the ISSCR 2026 Annual Meeting, the premier global gathering for stem cell research and regenerative medicine, to connect with scientific leaders and explore emerging advances shaping the future of the field.
A week-long, hands-on science camp for ages 11–14 exploring biotechnology, regenerative medicine, and real-world medical challenges—led by ARMI educators at the SEE Science Center.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
